Search Results

POS0692 IANALUMAB (VAY736) SAFETY AND EFFICACY IN PATIENTS WITH SJOGREN’S SYNDROME: 52 WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL

• Authors : Dörner, T.; Bowman, S. J.; Fox, R.

Subjects: General Biochemistry, Genetics and Molecular Biology; Immunology; Immunology and Allergy

• Source: Annals of the Rheumatic Diseases ; volume 80, issue Suppl 1, page 593-594 ; ISSN 0003-4967 1468-2060

Record details

APPA (apocynin and paeonol) modulates pathological aspects of human neutrophil function, without supressing antimicrobial ability, and inhibits TNFα expression and signalling

• Authors : Cross, A. L.; Hawkes, J.; Wright, H. L.

Subjects: Original Article

• Source: Inflammopharmacology

Record details

Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression

• Authors : Glennon-Alty, L; Moots, R J; Edwards, S W ...

Subjects: Immunology; Immunology and Allergy

• Source: Clinical & Experimental Immunology ; volume 203, issue 2, page 151-159 ; ISSN 0009-9104 1365-2249

Record details

OP0302 IANALUMAB (VAY736), A DUAL MODE OF ACTION BIOLOGIC COMBINING BAFF RECEPTOR INHIBITION WITH B CELL DEPLETION, REACHES PRIMARY ENDPOINT FOR TREATMENT OF PRIMARY SJOGREN’S SYNDROME

• Authors : Dörner, T.; Bowman, S. J.; Fox, R.

• Source: Annals of the Rheumatic Diseases ; volume 79, issue Suppl 1, page 187.1-188 ; ISSN 0003-4967 1468-2060

Record details

OP0220 ASSESSING THE EFFECT OF INCREASED BODY MASS INDEX ON RESPONSE TO TNF INHIBITORS IN ESTABLISHED RHEUMATOID ARTHRITIS: RESULTS FROM THE METEOR DATABASE

• Authors : Dey, M.; Zhao, S. S.; Moots, R. J.

Subjects: General Biochemistry, Genetics and Molecular Biology; Immunology; Immunology and Allergy

• Source: Annals of the Rheumatic Diseases ; volume 79, issue Suppl 1, page 137.1-137 ; ISSN 0003-4967 1468-2060

Record details

Type I interferon regulates cytokine‐delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.

• Authors : Glennon‐Alty, L.^1,2 (AUTHOR); Moots, R. J.³ (AUTHOR); Edwards, S. W.⁴ (AUTHOR)

Subjects: *TYPE I interferons; *REACTIVE oxygen species; *PULMONARY alveolar proteinosis

• Source: Clinical & Experimental Immunology. Feb2021, Vol. 203 Issue 2, p151-159. 9p. 2 Black and White Photographs, 2 Graphs.

Record details

Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin‐8, but do not inhibit priming of the respiratory burst or reactive oxygen species production

• Authors : Mitchell, T. S.; Moots, R. J.; Wright, H. L.

Subjects: Original Articles

Record details

Inflammatory arthritis in HIV positive patients: A practical guide

• Authors : Adizie, T; Moots, R J; Hodkinson, B

Subjects: Infectious Diseases; Parasitology; Medical Microbiology

• Source: BMC Infectious Diseases ; https://dx.doi.org/10.1186/s12879-016-1389-2 ; 16 ; 1 ; 174 - 177

Record details

Inflammatory arthritis in HIV positive patients: A practical guide

• Authors : Adizie, T.; Moots, R. J.; Hodkinson, B.

Subjects: Research Article

Record details

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

• Authors : Emery, P.; Gottenberg, J. E.; Rubbert-Roth, A. ...

Subjects: Rheumatoid Arthriti; DMARDs (biologic); Anti-TNF

Record details